Home  »  Stocks to Invest   »  Jaguar Health Inc. (JAGX) stock gained during pre-...

Jaguar Health Inc. (JAGX) stock gained during pre-market trading. What should you know about it?

Jaguar Health Inc. (JAGX) stock surged by 5.88% at the last trading close while the JAGX stock price rises by 11.11% at the last check in the pre-market trading. Jaguar Health, Inc. is a commercial-stage pharmaceutical company focusing on developing new, plant-based, non-opioid, and sustainably derived prescription drugs for people and animals suffering from gastrointestinal discomfort, especially chronic, crippling diarrhea. Napo Pharmaceuticals, Inc., the fully owned subsidiary, is focused on creating and commercializing patented plant-based human gastrointestinal pharmaceuticals derived from plants safely obtained from rainforest areas.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


What’s coming?

Jaguar Health sent a reminder today about the Innovators with Jane King interview with Lisa Conte, JAGX’s founder, president, and CEO, and Josh Mailman, the lead sponsor of the Dragon special purpose acquisition company (the “Dragon SPAC”), which will show during a webcast this Friday, April 23, 2021, to include a business analysis of Napo EU S.p.A. which is Jaguar’s wholly-owned subsidiary.

Recent Past Development

JAGX announced on April 15, 2021, that the at-the-market (“ATM”) financing program that Jaguar Health established with Ladenburg Thalmann & Co. on October 5, 2020, has been increased by $15.3 million for any future funding requirements. JAGX filed a registration statement and prospectus supplement on April 9, 2021, in accordance with its previously announced At “The Market Offering Agreement” with Ladenburg, as an agent, to increase the size of the at-the-market offering under which JAGX can offer and sell shares of Jaguar Health’s common stock from time to time via Ladenburg.

Lisa Conte, Jaguar’s president and CEO commented:

JAGX is ecstatic to have increased the ATM program’s potential. While Jaguar Health does not intend to issue any shares at this time, the upsized ATM system is intended to provide JAGX with future funding, if required, at the current market price at the time of sale, thus potentially priced at-the-market, or above-the-market, as defined by NASDAQ, based on timing.

Leave a Comment

Your email address will not be published. Required fields are marked *

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Biotech Stocks to Buy for Sep-2021

Biotechnology (biotech) refers to the use of microbes and cellular biology in health-related research and development. It is not just therapies that biotechnology companies develop.

635

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam